Article
Market share isn't the only metric for biosimilars' success
Rating:
0.0
Views:
74
Likes:
1
Library:
1
Although biosimilars make up less than half all drugs used to treat autoimmune diseases, they have not failed. Medicare data show they have been a huge success.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value